Page 245 - 2021_10-Haematologica-web

Letters to the Editor
dissection of AML reveals progenitor-like cells that correlate with
prognosis. Cell. 2015;162(1):184-197.
4. Anderson BE, McNiff J, Yan J, et al. Memory CD4+ T cells do not
induce graft-versus-host disease. J Clin Invest. 2003;112(1):101-108.
5. Chen BJ, Deoliveira D, Cui X, et al. Inability of memory T cells to induce graft-versus-host disease is a result of an abortive allore-
sponse. Blood. 2007;109(7):3115-3123.
6. Roberto A, Castagna L, Zanon V, et al. Role of naive-derived T
memory stem cells in T-cell reconstitution following allogeneic
transplantation. Blood. 2015;125(18):2855-2864.
7. Cieri N, Oliveira G, Greco R, et al. Generation of human memory
stem T cells after haploidentical T-replete hematopoietic stem cell
transplantation. Blood. 2015;125(18):2865-2874.
8. Kanakry CG, Ganguly S, Zahurak M, et al. Aldehyde dehydroge-
nase expression drives human regulatory T cell resistance to post- transplantation cyclophosphamide. Sci Transl Med. 2013;5(211):211ra157.
9. Wachsmuth LP, Patterson MT, Eckhaus MA, Venzon DJ, Gress RE, Kanakry CG. Posttransplantation cyclophosphamide prevents graft- versus-host disease by inducing alloreactive T cell dysfunction and suppression. J Clin Invest. 2019;129(6):2357-2373.
10.Suessmuth Y, Mukherjee R, Watkins B, et al. CMV reactivation
drives posttransplant T-cell reconstitution and results in defects in
the underlying TCRb repertoire. Blood. 2015;125(25):3835-3850. 11. Kanakry CG, Coffey DG, Towlerton AMH, et al. Origin and evolu- tion of the T cell repertoire after posttransplantation cyclophos-
phamide. JCI Insight. 2016;1(5):e86252.
12. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-
lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 1996;70(11):7569-7579.
13.Huntley D, Giménez E, Pascual MJ, et al. Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide. Bone Marrow Transplant. 2020;55(7):1347-1356.
14. Camargo JF, Wieder ED, Kimble E, et al. Deep functional immunophenotyping predicts risk of cytomegalovirus reactivation after hematopoietic cell transplantation. Blood. 2019;133(8):867- 877.
15. Pelák O, Stuchlý J, Król L, et al. Appearance of cytomegalovirus-spe- cific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation. Cytometry B Clin Cytom. 2017;92(5):380- 388.
haematologica | 2021; 106(10)
2773